Geode Capital Management, LLC Codiak Bio Sciences, Inc. Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.18 - $0.81 $25,208 - $113,436	-140,045 Reduced 86.52%	21,826 $3,000
Q4 2022 Feb 13, 2023	SELL	$0.32 - $0.9 $121 - $341	-379 Reduced 0.23%	161,871 $64,000
Q3 2022 Nov 14, 2022	BUY	$0.82 - $3.19 $517 - $2,012	631 Added 0.39%	162,250 $126,000
Q2 2022 Aug 12, 2022	SELL	$2.24 - $6.96 $303,452 - $942,871	-135,470 Reduced 45.6%	161,619 $465,000
Q1 2022 May 13, 2022	BUY	$4.3 - $12.95 $182,986 - $551,087	42,555 Added 16.72%	297,089 $1.86 Million
Q4 2021 Feb 11, 2022	BUY	$10.0 - $16.78 $245,930 - $412,670	24,593 Added 10.7%	254,534 $2.84 Million
Q3 2021 Nov 12, 2021	BUY	$15.58 - $22.88 $364,011 - $534,568	23,364 Added 11.31%	229,941 $3.75 Million
Q2 2021 Aug 13, 2021	BUY	$11.72 - $26.81 $971,646 - $2.22 Million	82,905 Added 67.04%	206,577 $3.83 Million
Q1 2021 May 12, 2021	BUY	$13.49 - $31.53 $677,400 - $1.58 Million	50,215 Added 68.36%	123,672 $1.86 Million
Q4 2020 Feb 12, 2021	BUY	$7.9 - $32.3 $580,310 - $2.37 Million	73,457 New	73,457 $2.37 Million

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.